In the News
CHC’s Bone Health Clinic featured on WoodTV8
Working hard to further progress in cancer treatments.
08/06/2019
CHC’s Bone Health Clinic was featured on Wood TV 8 yesterday, August 5th. To see the episode and Tanya Rowerdink, NP – our Director of Multispecialty Services – speaking about all the wonderful work done there, click the link below. Read more »
CHC’s Dr. Sreenivasa Chandana Published in The Journal of Gastrointestinal Oncology
Working hard to further progress in cancer treatments.
06/27/2019
CHC’s Dr. Sreenivasa Chandana was recently published in the Journal of Gastrointestinal. The article, titled Survival Trends of Metastatic Small Intestinal Neuroendocrine Tumor: A Population-Based Analysis of SEER Database aims “to analyze survival trends in metastatic SNET patients stratified by Read more »
START Midwest & Dr. Nehal Lakhani on WoodTV8
Working hard to further progress in cancer treatments.
06/27/2019
CHC’s START Midwest clinical trials program was featured on Wood TV 8 last Friday, June 21st. To see the episode and Dr. Nehal Lakhani speaking about all the wonderful work done there, click the link below. Watch the Video Read more »
CHCWM’s Muskegon Group is on the Move – August 26
Working hard to further progress in cancer treatments.
06/24/2019
CHC is proud to announce that we’re still growing, and that means a new, bigger facility for our Muskegon group! We will be moving on August 26 to our new location at 6425 South Harvey Street. For More Details Read more »
CHCWM’s Involvement in Resilient Trials & ASCO Announcement
Working hard to further progress in cancer treatments.
05/31/2019
RESILIENT trial results will be released in lung cancer poster section on this Sunday morning (June 2, 2019) at ASCO annual meeting. CHCWM is the 3rd largest recruiter on the planet and the largest recruiter in the US. Excellent work Read more »
CHCWM’s Dr. Yuanbin Chen – Journal of Thoracic Oncology
Working hard to further progress in cancer treatments.
05/22/2019
CHC’s Yuanbin Chen, MD is a contributing author in the Journal of Thoracic Oncology’s article “Durvalumab in Combination with Olaparib in Patients with Relapsed Small Cell Lung Cancer: Results from a Phase II Study”. Read the Article Read more »